Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2025-12-16 @ 5:12 PM
Study NCT ID:
NCT06102759
Status:
None
Last Update Posted:
2023-10-26 00:00:00
First Post:
2023-10-22 00:00:00
Brief Title:
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Organization Data
Organization:
Tianjin Medical University Cancer Institute and Hospital
Class:
OTHER
Study ID:
TJMUCH-GI-GC04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None